The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study.

Gabor CserepDavid MorrowKaren LatchfordRachael JessetAgnes DosaDimitrios Kirmizis

Published in: Clinical and experimental nephrology (2021)

The BNT162b2 vaccine can be safely used in HD patients and seems to offer significant protection against the infection even after the first vaccine dose.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
newly diagnosed
ejection fraction
prognostic factors
risk factors
early onset
patient reported outcomes
patient reported